On the other hand, the bivalent αFAP-IgG4 TM has extended blood circulation and longer retention time at the tumor site, resulting in a prolonged and more efficient inhibition of tumor growth over time without the need for continuous TM infusion. This evidence concerns the gene AFAP1 and neoplasm.